Complete report $3,850. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 125 pages and 24 tables
SIMILAR MARKET STUDIES
This new report from Venture Planning Group contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital coagulation testing market, including:
November 2013 | $3900 | View Details >>
2016 Global Sexually Transmitted Diseases (STDs) Testing Market Report is a professional and in-depth research report on the world's major regional market conditions of the Sexually Transmitted Diseases (STDs) Testing industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and ...
September 2016 | $2850 | View Details >>
This new 278-page report from VPGMarketResearch.com provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
February 2015 | $2900 | View Details >>
?New Frontiers in Point-of-Care/POC Diagnostic Testing: Global Challenges, Emerging Technologies, Competitive Landscape? is Venture Planning Group?s new report, which provides comprehensive analysis of the ten POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
May 2014 | $16600 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research